Johnson City, Tennessee – NN Inc., a diversified industrial company, announced it has completed the validation and production readiness certification of its additive manufacturing (DMLS) process technology for the medical device industry.
"We are pleased to release this new technology to help our customers reach new levels of more advanced product designs" said John Manzi, Senior vice president PEP group. "Additive manufacturing (DMLS) technologies can reduce costs and lead-times while enhancing product performance. We are proud to add this latest technology to our comprehensive technology platform."
NN's customers who specialize in orthopedic instruments and implants have been among the early implementers of this technology. As the technology continues to evolve, the company expects it will extend across the entire medical device industry as well as into other end markets.
NN Inc., a diversified industrial company combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Johnson City, Tennessee, NN has 42 manufacturing plants in North America, Western Europe, Eastern Europe, South America and China.
Source: NN Inc.
Latest from Today's Medical Developments
- Teleflex sells acute care and urology businesses for $2.03 billion
- HANNOVER MESSE: Where research and manufacturing meet
- What’s next for the design and manufacturing industry in 2026?
- Arcline to sell Medical Manufacturing Technologies to Perimeter Solutions
- Decline in German machine tool orders bottoming out
- Analysis, trends, and forecasts for the future of additive manufacturing
- BlueForge Alliance Webinar Series Part III: Integrate Nationally, Catalyze Locally
- Robot orders accelerate in Q3